Index 
 Previous 
 Next 
 Full text 
Procedure : 2018/2782(RSP)
Document stages in plenary
Select a document :

Texts tabled :

O-000134/2018 (B8-0006/2019)

Debates :

PV 12/02/2019 - 22
CRE 12/02/2019 - 22

Votes :

Texts adopted :


Minutes
Tuesday, 12 February 2019 - StrasbourgFinal edition

22. Policy challenges and strategies against women's cancers and related comorbidities (debate)
CRE

Question for oral answer (O-000134/2018) by Daniela Aiuto, on behalf of the FEMM Committee, to the Commission: Policy challenges and strategies against women's cancers and related comorbidities (B8-0006/2019)

Daniela Aiuto moved the question.

IN THE CHAIR: Mairead McGUINNESS
Vice-President

Vytenis Povilas Andriukaitis (Member of the Commission) answered the question.

The following spoke: Marijana Petir, on behalf of the PPE Group, Biljana Borzan, on behalf of the S&D Group, Jana Žitňanská, on behalf of the ECR Group, Lieve Wierinck, on behalf of the ALDE Group, Ángela Vallina, on behalf of the GUE/NGL Group, Agnieszka Kozłowska-Rajewicz, Jadwiga Wiśniewska, Michaela Šojdrová and Francis Zammit Dimech.

The following spoke under the catch-the-eye procedure: Anna Záborská, Julie Ward, Notis Marias, Ana Miranda, Stanislav Polčák, Soledad Cabezón Ruiz and Dubravka Šuica

The following spoke: Vytenis Povilas Andriukaitis.

Motion for a resolution to wind up the debate tabled under Rule 128(5):

—   Daniela Aiuto, on behalf of the FEMM Committee, on policy challenges and strategies against women’s cancers and related comorbidities (2018/2782(RSP)) (B8-0097/2019).

The debate closed.

Vote: minutes of 13.2.2019, item 16.10.

Last updated: 5 August 2019Legal notice